Nouri Alaleh 4
4 · PROCEPT BioRobotics Corp · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
PROCEPT BioRobotics EVP Nouri Alaleh Sells Shares
What Happened Nouri Alaleh, EVP, CLO and Corporate Secretary of PROCEPT BioRobotics (PRCT), sold a total of 3,243 shares on March 10, 2026 in open-market transactions. The filings show 3,098 shares disposed at a weighted average price of $25.60 (total $79,320) and 145 shares disposed at a weighted average price of $26.74 (total $3,877), for aggregate proceeds of $83,197. These were sales (not purchases) and were effected pursuant to a prearranged Rule 10b5-1 trading plan.
Key Details
- Transaction date: 2026-03-10; Form 4 filed: 2026-03-12 (timely — within the standard two business days).
- Quantities & prices reported:
- 3,098 shares at weighted avg $25.60 (per-share range $25.11–$25.96) — footnote F2.
- 145 shares at weighted avg $26.74 (per-share range $26.365–$26.98) — footnote F3.
- Total shares sold: 3,243; total proceeds reported: $83,197.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Notable footnote: F1 — sales were made under a Rule 10b5-1 trading plan adopted June 4, 2025. F2/F3 note weighted-average pricing and provide ranges; the filer will disclose per-price breakdown on request.
Context Sales executed under a 10b5-1 plan are prearranged and often routine, allowing insiders to trade according to a schedule regardless of subsequent inside information; they do not necessarily indicate a change in the insider’s view of the company. For retail investors, purchases by insiders tend to be more informative about confidence than routine sales; this filing documents scheduled disposition of stock.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-03-10$25.60/sh−3,098$79,320→ 111,166 total - Sale
Common Stock
[F1][F3]2026-03-10$26.74/sh−145$3,877→ 111,021 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.11 to $25.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.365 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.